Skip to main content
Toggle navigation
Login
Search
Home
Browse by Speaker
Home
Browse by Speaker
Browse by Speaker
Type here to filter the list
All
A
B
C
D
E
F
G
H
I
J
K
L
M
N
O
P
Q
R
S
T
U
V
W
X
Y
Z
K
Kakuturu, Raja
Exact Sciences Laboratories
A Refresher in R: Using R in Validations in the Clinical Pathology Lab
Location: 253ABC, Level 2
Raja Kakuturu
Kargaran, Parisa
Mayo Clinic
Dual Balanced Insertions on Chromosome 2 Identified in a Carrier Mother: Implications for Recurrent Copy Number Variants in Offspring
Location: 153ABC, Level 1
Parisa Kargaran
Karunamurthy, Arivarasan
University of Pittsburgh Medical Center
Advances in Oncogenic Evaluation and Nomenclature of Gene Fusions in Solid Tumors
Location: 153ABC, Level 1
Arivarasan Karunamurthy
Plenary Solid Tumors
Location: 153ABC, Level 1
Arivarasan Karunamurthy
Transforming Cancer Care with Cell-Free DNA Testing
Location: 153ABC, Level 1
Arivarasan Karunamurthy
Uncovering Clinically Significant Gene Fusions & Neoantigens: Challenges and Innovations in Tumor Profiling
Location: 153ABC, Level 1
Arivarasan Karunamurthy
Kelly, Libusha
Albert Einstein College of Medicine
Large Language Models for Annotation of Prokaryotic Viral Proteins
Location: 157ABC, Level 1
Libusha Kelly
Kester, Dr. Lennart
Prinses Máxima Centrum voor kinderoncologie
Reimagining NGS Prep: End-to-End Automation for Faster Clinical Insights
Location: 160C, Level 1
Dr. Lennart Kester
Khaksar, Ramin
Clear Labs, Inc.
Advancing Oncology Workflows Through End-to-End Automation
Location: Innovation Spotlight Stage #3
Ramin Khaksar
Khalil, Farah
Moffit Cancer Center, Tampa Florida
Navigating MET Aberrations in NSCLC: Implications for Pathologists, Oncologists, and for Targeted Therapies
Location: 151AB, Level 1
Farah Khalil
Khan, Osama
Natera
Practical Considerations for Molecular Pathologists: Navigating Tissue-Informed MRD Testing with Signatera
Location: 155, Level 1
Osama Khan
Khan, Wahab
Dartmouth
Platform Presentations of Selected Genetics Abstracts
Location: 157ABC, Level 1
Wahab Khan
Kiel, Mark
Revealing the Value of Literature-Based Real-World Evidence: Transforming Trial Design, Label Expansion, and Clinical Decision-Making
Location: 156AB, Level 1
Mark Kiel
Kim, Adriel
Nationwide Children's Hospital
Homozygosity for the SMN2 c.859G>C Allele Accounts for the Phenotypic and Genotypic Discordances Seen in an Uncommon Case of Spinal Muscular Atrophy Revealed by Newborn Screening
Location: 153ABC, Level 1
Adriel Kim
Kim, Annette
University of Michigan
Closing Remarks
Location: 153ABC, Level 1
Annette Kim
Optimizing Molecular Testing and Reporting for Myeloid Malignancies: Bridging Oncologist Expectations with Laboratory Practicalities (Panel discussion)
Location: 157ABC, Level 1
Annette Kim
Klemm, Florian
SOPHiA GENETICS
Redefining Precision Oncology with MSK-ACCESS® powered with SOPHiA DDM™
Location: 160C, Level 1
Florian Klemm
Knox, Curtis
Watchmaker Genomics
Built for the Front Line: Advances in qPCR and RPA for Point-of-Care Pathogen Detection
Location: 153C, Level 1
Curtis Knox
Kolhe, Ravindra
Augusta University
Advances in Ultra-Sensitive Genomic Technologies for Cancer and Infectious Disease Diagnostics.
Location: 160B, Level 1
Ravindra Kolhe
Konnick, Eric
University of Washington
LDTs Under the Microscope: Regulatory and Legislative Updates
Location: 258ABC, Level 2
Eric Konnick
Krishnamurthy, Kritika
Montefiore Medical Center
Harnessing Automated NGS for Myeloid Genomic Profiling and T-cell Clonality Detection
Location: 153A, Level 1
Kritika Krishnamurthy
Krystel-Whittemore, Mel
AstraZeneca
Genomic Alterations in the PI3K-AKT-PTEN Pathway: Advancing Diagnostic Strategies in Breast and Prostate Cancers
Location: 160A, Level 1
Mel Krystel-Whittemore
